[
  {
    "ts": "2026-01-11T06:00:19+00:00",
    "headline": "ABIVAX Société Anonyme (ABVX) Rumored To Attract Interest From Eli Lilly",
    "summary": "ABIVAX Société Anonyme (NASDAQ:ABVX) is among the 20 Best Performing Stocks in 2025. According to a story in the French-language newspaper La Tribune on December 24, 2025, there have been rumors that Eli Lilly has been drawing interest in the French biotechnology business ABIVAX Société Anonyme (NASDAQ:ABVX), TheFly reported. Its shares surged after the release, […]",
    "url": "https://finance.yahoo.com/news/abivax-soci-t-anonyme-abvx-060019166.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "d40351b7-56cd-3461-badd-50d7ef1b07df",
      "content": {
        "id": "d40351b7-56cd-3461-badd-50d7ef1b07df",
        "contentType": "STORY",
        "title": "ABIVAX Société Anonyme (ABVX) Rumored To Attract Interest From Eli Lilly",
        "description": "",
        "summary": "ABIVAX Société Anonyme (NASDAQ:ABVX) is among the 20 Best Performing Stocks in 2025. According to a story in the French-language newspaper La Tribune on December 24, 2025, there have been rumors that Eli Lilly has been drawing interest in the French biotechnology business ABIVAX Société Anonyme (NASDAQ:ABVX), TheFly reported. Its shares surged after the release, […]",
        "pubDate": "2026-01-11T06:00:19Z",
        "displayTime": "2026-01-11T06:00:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/df03d92787e31496aedb5cfc8db21ced",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "ABIVAX Société Anonyme (ABVX) Rumored To Attract Interest From Eli Lilly, La Tribune Says",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R1z16qs9g.7ct2NxOWvrZg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/df03d92787e31496aedb5cfc8db21ced.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RJep62..wom2drsNozzO6g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/df03d92787e31496aedb5cfc8db21ced.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abivax-soci-t-anonyme-abvx-060019166.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abivax-soci-t-anonyme-abvx-060019166.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AAVXF"
            },
            {
              "symbol": "ABVX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-11T14:00:25+00:00",
    "headline": "Can Eli Lilly and Company's (NYSE:LLY) ROE Continue To Surpass The Industry Average?",
    "summary": "While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...",
    "url": "https://finance.yahoo.com/news/eli-lilly-companys-nyse-lly-140025898.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ead81000-862e-3230-91f9-9e9c2989a5f9",
      "content": {
        "id": "ead81000-862e-3230-91f9-9e9c2989a5f9",
        "contentType": "STORY",
        "title": "Can Eli Lilly and Company's (NYSE:LLY) ROE Continue To Surpass The Industry Average?",
        "description": "",
        "summary": "While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...",
        "pubDate": "2026-01-11T14:00:25Z",
        "displayTime": "2026-01-11T14:00:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-companys-nyse-lly-140025898.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-companys-nyse-lly-140025898.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-11T14:55:00+00:00",
    "headline": "This Healthcare Stock Could Be One of the Best Companies to Own in 2026",
    "summary": "It has strong momentum thanks to its current portfolio and several catalysts on the horizon.",
    "url": "https://www.fool.com/investing/2026/01/11/this-healthcare-stock-could-be-one-of-the-best-com/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "873e773a-4ba1-3be7-86b6-339d375c9abd",
      "content": {
        "id": "873e773a-4ba1-3be7-86b6-339d375c9abd",
        "contentType": "STORY",
        "title": "This Healthcare Stock Could Be One of the Best Companies to Own in 2026",
        "description": "",
        "summary": "It has strong momentum thanks to its current portfolio and several catalysts on the horizon.",
        "pubDate": "2026-01-11T14:55:00Z",
        "displayTime": "2026-01-11T14:55:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/66c6177bc8b44cebaccf8947ae1c87b3",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Patient taking medicine.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Hn.LmatH_kbOXRjUuneNHA--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/66c6177bc8b44cebaccf8947ae1c87b3.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HKlfIIbQ34VZZotSc4i7wQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/66c6177bc8b44cebaccf8947ae1c87b3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/11/this-healthcare-stock-could-be-one-of-the-best-com/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/healthcare-stock-could-one-best-145500329.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-11T22:30:00+00:00",
    "headline": "Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion",
    "summary": "CHICAGO, January 11, 2026--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a record Total Contract Value (TCV) of >$1.1 billion as of December 31, 2025. During 2025, Tempus signed data agreements with over 70 customers, spanning both large and mid-sized pharma, including AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, Novartis, Merck, Abbvie, Daiichi Sankyo, Eli Lilly, Boehringer Ingelheim, and biotechs inc",
    "url": "https://finance.yahoo.com/news/tempus-achieves-record-total-contract-223000270.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "8892092e-f66b-3479-94d4-b3c8001dae8f",
      "content": {
        "id": "8892092e-f66b-3479-94d4-b3c8001dae8f",
        "contentType": "STORY",
        "title": "Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion",
        "description": "",
        "summary": "CHICAGO, January 11, 2026--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a record Total Contract Value (TCV) of >$1.1 billion as of December 31, 2025. During 2025, Tempus signed data agreements with over 70 customers, spanning both large and mid-sized pharma, including AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, Novartis, Merck, Abbvie, Daiichi Sankyo, Eli Lilly, Boehringer Ingelheim, and biotechs inc",
        "pubDate": "2026-01-11T22:30:00Z",
        "displayTime": "2026-01-11T22:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/5ef6c4c591b248a3412b0a0ddce16d95",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0nbf7GAz1pqC3MjJDGb2gQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/5ef6c4c591b248a3412b0a0ddce16d95.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zhEUBsdXIkyOKFrh_p9sEQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5ef6c4c591b248a3412b0a0ddce16d95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tempus-achieves-record-total-contract-223000270.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tempus-achieves-record-total-contract-223000270.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "4388.T"
            },
            {
              "symbol": "TEM"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "DSKYF"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "WHWK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-11T16:03:00+00:00",
    "headline": "This ETF Is Proof That the Healthcare Rebound Is Real",
    "summary": "Track healthcare’s 2026 setup: GLP-1 drug adoption, a valuation gap vs. tech, and why VHT offers broad exposure with low fees and dividends.",
    "url": "https://www.marketbeat.com/originals/this-etf-is-proof-that-the-healthcare-rebound-is-real/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "021e66ae-183c-308d-8a24-6c4404ad6e5b",
      "content": {
        "id": "021e66ae-183c-308d-8a24-6c4404ad6e5b",
        "contentType": "STORY",
        "title": "This ETF Is Proof That the Healthcare Rebound Is Real",
        "description": "",
        "summary": "Track healthcare’s 2026 setup: GLP-1 drug adoption, a valuation gap vs. tech, and why VHT offers broad exposure with low fees and dividends.",
        "pubDate": "2026-01-11T16:03:00Z",
        "displayTime": "2026-01-11T16:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/d0b030cbc514357d4ca88578c9786536",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Caduceus symbol on trading floor with rising stock charts, highlighting healthcare stocks and market momentum.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Hocz2O5hucEGA2l3AG6LkQ--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/d0b030cbc514357d4ca88578c9786536.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RV6ZmN4p6FdLkswQuKrHdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/d0b030cbc514357d4ca88578c9786536.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/originals/this-etf-is-proof-that-the-healthcare-rebound-is-real/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/etf-proof-healthcare-rebound-real-160300473.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "HCA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "VHCIX"
            },
            {
              "symbol": "VHT"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "ELV"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]